Accelerated Seldinger at AVA

0

The Accelerated Seldinger Technique reduces the danger of air embolism while providing fail-safe needlestick protection and faster access. Those were among the conclusions of research presented at the annual conference of the Association for Vascular Access (AVA).

A talk by Steve Bierman, M.D., described the results of a study led by Bonnie Smith, R.N., manager of the IV therapy department at a Florida medical center. Smith’s research compared the Accelerated Seldinger Technique (AST) to the Modified Seldinger Technique (MST), a widespread, though sometimes problematic approach to placing central catheters.

The research, which compared the device to MST under simulated conditions, produced three results:

  • Substantially fewer “open-to-air” events. There were 50% fewer “open-to-air” events with AST than with MST, indicating a reduced risk of air embolism.
  • Needlestick safety. The WAND’s needlestick safety feature appeared to be failure-proof.
  • Much faster speed of access. The time to complete AST — 11.3 seconds — was more than three times faster than the time to complete MST (38.8 seconds).

Click here for the full story on Marketwatch.
A talk by Steve Bierman, M.D., described the results of a study led by Bonnie Smith, R.N., manager of the IV therapy department at a Florida medical center. Smith’s research compared the Accelerated Seldinger Technique (AST) to the Modified Seldinger Technique (MST), a widespread, though sometimes problematic approach to placing central catheters.

The research, which compared the device to MST under simulated conditions, produced three results:

  • Substantially fewer “open-to-air” events. There were 50% fewer “open-to-air” events with AST than with MST, indicating a reduced risk of air embolism.
  • Needlestick safety. The WAND’s needlestick safety feature appeared to be failure-proof.
  • Much faster speed of access. The time to complete AST — 11.3 seconds — was more than three times faster than the time to complete MST (38.8 seconds).

Click here for the full story on Marketwatch.

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.